The first HIV AIDS case in Turkey was diagnosed in 1985. HIV-1 subtype B is the dominant type in Turkey, followed by circulating recombinant forms (CRF).

It is aimed to determine the HIV seropositivity rates among the samples sent for anti-HIV 1/2 test to the diagnostic Virology laboratory of Ege University Hospital and blood donors attended to the Blood Bank of Ege University during five years (June 2009 to June 2014).

Method: HIV infection is screened with anti-HIV 1/2 test (Architect, Abbott, USA), samples found to be positive are repeated with another system (Vidas, BioMerieux; USA). Supplemental (confirmatory) test is performed with Inno-LIA (Innogenetics, Belgium). HIV-1 viral load test is performed when HIV infection is confirmed.

Results: Anti-HIV test had been performed on 93917 serum samples (52810 females, 41107 males) in the diagnostic laboratory and 113055 blood donors. HIV-1 infection was confirmed in 135 (0.14%) patients (31 females, 104 males) in the diagnostic laboratory. Majority of the patiens belonged to the age group 25-49 (52.37%), followed by age groups; over 49 (26.10%), 15-24 (11.27%), and 0-14 (10.25%). Anti-HIV screening test was found to be positive in 50 donors (0.044%). They were called, 33 came and seven donors were confirmed and HIV-1 RNA was found to be positive (0.0062%).